MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers — their effects and therapeutic potentials
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 37, 142-150
Abstract
No abstract availableKeywords
Funding Information
- AM Cancer Soc (IRG-67-003-50)
- NIH (R03 NS102861)
- NIH (R35 CAI97706)
This publication has 60 references indexed in Scilit:
- Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's diseaseJournal of Gastroenterology and Hepatology, 2017
- miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RDClinical Cancer Research, 2017
- The microbiota in inflammatory bowel disease: current and therapeutic insightsJournal of Inflammation Research, 2017
- miR‐200b‐containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial‐mesenchymal transitionJournal of Gastroenterology and Hepatology, 2017
- The miR-200 family is increased in dysplastic lesions in ulcerative colitis patientsPLOS ONE, 2017
- MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease PhenotypesPLOS ONE, 2016
- Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel diseaseGenome Biology, 2016
- MicroRNA 429 Regulates Mucin Gene Expression and Secretion in Murine Model of ColitisJournal of Crohn's and Colitis, 2016
- Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial CellsCellular and Molecular Gastroenterology and Hepatology, 2015
- MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancerImmunological Reviews, 2013